Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer

Abstract

Among participants with biopsy-proven anal HSIL, the risk of anal cancer was significantly lower with treatment for anal HSIL than with active monitoring. (Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT02135419.).